Here are nine things to know:
1. The company’s global revenues reached $67.4 million.
2. RTI Surgical achieved its net income per fully diluted share of $0.03.
3. The company’s global direct revenues hit $38.7 million, representing an 11 percent increase over the first quarter of 2015.
4. The spine revenues saw a 17 percent increase over the same period the year prior, at $17.1 million.
5. International revenues reached $5.5 million, an 18 percent increase over the same period in 2015.
6. Global commercial revenue reached $25.3 million.
7. Adjusted EBITDA was $9.1 million, compared to $10.7 million for the first quarter of 2015.
7. RTI Surgical and Oxford Performance Materials signed an agreement to exclusively license its three-dimensional printing technology platform and OXPEKK polymer to manufacture spinal implants for U.S. markets.
8. The company also unveiled its Unison-C Anterior Cervical Fixation System, Streamline TL Spinal Fixation System and Release Laminoplasty Fixation System.
9. RTI Surgical expects second quarter revenue will range between $66 million and $67 million.
“Results for the quarter were in line with our outlook,” said Brian K. Hutchison, president and CEO, RTI Surgical. “Strong growth in our direct business offset expected declines in our commercial business.”
More articles on devices:
Wenzel Spine’s VariLift-LX on full US commercial launch: 5 key notes
4th patient in INSPIRE study experiences AIS grade improvement: 5 things to know
Dr. Richard Ostrup uses Zeiss microscope for neurosurgery procedures: 5 highlights
